Newbury Pharmaceuticals AB (publ) provided earnings guidance for the year 2028. For the period, the company expects to achieve sales of SEK 350 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.22 SEK | -3.01% | -6.94% | +4.89% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.89% | 7.37M | |
-12.65% | 7.93B | |
+33.84% | 1.3B | |
-9.90% | 346M | |
+6.86% | 278M | |
+9.44% | 222M | |
-34.86% | 62.09M | |
+26.51% | 60.97M |
- Stock Market
- Equities
- NEWBRY Stock
- News Newbury Pharmaceuticals AB
- Newbury Pharmaceuticals AB Provides Earnings Guidance for the Year 2028